AICD Interrogations Reveal Device Function, Arrhythmia Episodes, and Therapy Delivery
AICD interrogations show stored arrhythmia events with electrograms, device therapies delivered (shocks and antitachycardia pacing), battery status, lead parameters (sensing thresholds, pacing impedance, shock impedance), pacing percentages, and automatic alerts for device malfunction or clinical events 1.
Core Information Retrieved During Interrogation
Arrhythmia Detection and Stored Events
- Stored electrograms of rhythms immediately before and after tachycardia detection and therapy 2
- Ventricular tachycardia (VT) and ventricular fibrillation (VF) episodes with cycle length data and episode duration 3
- Supraventricular tachyarrhythmias that may trigger inappropriate device therapy, particularly atrial fibrillation with rapid ventricular response 4
- Event logs documenting all detected arrhythmias and device activations 5, 2
Device Therapy Documentation
- Appropriate ICD shocks for VT/VF termination 6
- Antitachycardia pacing (ATP) episodes and their success rates - studies show ATP terminates 96% of detected VT episodes 2
- Inappropriate therapies delivered for supraventricular arrhythmias or oversensing 3, 7
- Failed therapies including undersensing of VF, inadequate shock delivery, or refractory arrhythmias 8, 9
Technical Device Parameters
- Battery voltage and charge time to assess device longevity 1
- Lead impedance for both pacing and shock pathways 1
- Sensing thresholds in atrium and ventricle 1, 10
- Automatically measured pacing thresholds when available 1
- Percent pacing in each chamber 1
Clinical Significance of Interrogation Findings
Detection of Device Malfunction
Interrogation identifies lead fractures, sensing failures, and inappropriate shock delivery 7. A critical finding from postmortem studies: ICD-related problems (undersensing or proarrhythmia) caused sudden death in up to 25% of cases where devices were interrogated after death 8, 11.
Arrhythmia Burden Assessment
- Frequent VT episodes may require antiarrhythmic drug adjustment 10
- Nonsustained VT detection helps guide programming changes 6
- Arrhythmia storm (multiple recurrent episodes) requires immediate intervention 4
Programming Optimization
Interrogation data guides adjustments to:
- Detection zones and rates (typically 180-200 bpm for primary prevention) 3
- Detection delays (8-15 seconds for rates 180-200 bpm; 3-7 seconds for rates >250 bpm) 3
- Discrimination algorithms to reduce inappropriate therapy 3
Common Pitfalls Revealed by Interrogation
Undersensing of VF occurs when ventricular electrograms have intermittent high amplitude or low amplitude signals, causing delayed or absent therapy 8, 9. This is particularly problematic in hypertrophic cardiomyopathy patients 9.
Inappropriate shocks from supraventricular tachycardia remain common despite advanced algorithms, occurring in 10-15% of dual-chamber devices 4. Interrogation helps differentiate these from appropriate therapies.
Asymptomatic arrhythmias: Studies show 47% of patients with sustained VT triggering ICD discharge were asymptomatic beforehand 6, making interrogation essential for detecting silent but life-threatening events.
Frequency and Method of Interrogation
Per ACC/AHA/HRS guidelines 1:
- Within 72 hours post-implantation (in-person)
- 2-12 weeks post-implantation (in-person)
- Every 3-6 months for ICDs (in-person or remote)
- Every 1-3 months when battery depletion signs appear
- Immediately after any ICD therapy delivery 5, 2
Remote monitoring with wireless telemetry provides the same comprehensive data as in-office visits and enables automatic alerts for abnormal battery voltage, lead parameters, or increased arrhythmia frequency 1.
Postmortem Interrogation
Postmortem device interrogation should be performed routinely but is severely underutilized 11. In the MADIT-CRT trial, only 24 of 39 sudden deaths had interrogation performed 8. These revealed that 33% had fatal VT/VF (with 25% showing inadequate ICD performance), while 54% had no tachyarrhythmia detected, suggesting either non-arrhythmic death or critical undersensing 8.